PHILADELPHIA –The escalating trade war between the United States and China dominated most of the discussion during the China Summit meeting at the Biotechnology Innovation Organization' (BIO) international convention.
PERTH, Australia – After a AU$2 million (US$1.4 million) capital raise in April, Perth-headquartered Pharmaust Ltd. will advance its lead compound monepantel into phase I trials in humans.
PHILADELPHIA – This year's Australian delegation saw the most impressive participation to date at the Biotechnology Innovation Organization's (BIO) 2019 conference, with more than 150 Australian companies participating as well as numerous government representatives.
PERTH, Australia – After a AU$2 million (US$1.4 million) capital raise in April, Perth-headquartered Pharmaust Ltd. will advance its lead compound monepantel into phase I trials in humans.
PHILADELPHIA – This year's Australian delegation saw the most impressive participation to date at the Biotechnology Innovation Organization's (BIO) 2019 conference, with more than 150 Australian companies participating as well as numerous government representatives.
PHILADELPHIA –The escalating trade war between the United States and China dominated most of the discussion during the China Summit meeting at the Biotechnology Innovation Organization' (BIO) international convention here on Tuesday.
PHILADELPHIA – Shanghai-based Epimab Biotherapeutics Inc. raised $74 million in a series B round to advance its phase I/II lead candidate, EMB-01, and expand its pipeline into immuno-oncology.
PERTH, Australia – Probably nobody was as surprised by the results of Australia's national election than re-elected Liberal Party Prime Minister Scott Morrison, but he has a lot to answer to when it comes to policy initiatives that affect the life sciences sector here.
